More Options in New Childhood Vaccine Recommendations

Families may continue with the existing schedule or discuss changes with their physicians, although questions remain about availability, insurance coverage and additional office visits.

Delivering Gold Standard Childhood Vaccine Recommendations for Americans – an Executive Order

President Donald Trump signed an executive order Monday establishing what the administration calls its “Gold Standard Childhood Vaccine Recommendations,” a new framework intended to give parents and physicians greater flexibility in deciding which childhood vaccines to administer—and when to administer them.

The overriding message during the White House announcement was one of choice rather than prohibition. Administration officials stressed that no vaccines are being banned or removed from the market and that parents who are comfortable following the existing approach may continue to do so. Parents who prefer to space out vaccines, limit the number administered during a single appointment or make other changes may discuss those options with their child’s physician.

Under the new framework, 11 childhood immunizations would continue to be routinely recommended for all children, down from the 18 included in the Centers for Disease Control and Prevention’s 2024 schedule.

Vaccines removed from the universal recommendation would remain available through “shared clinical decision-making,” allowing parents and medical providers to consider a child’s health, individual risk factors and family preferences.

One of the most significant recommendations involves the timing and combination of vaccines. The administration recommends that vaccines be administered during separate medical visits rather than giving several during the same appointment. It also calls for the combined measles, mumps and rubella vaccine—commonly known as MMR—to be made available as three individual vaccines.

That portion of the plan cannot be implemented immediately. Single-antigen measles, mumps and rubella vaccines are not currently available in the United States as they are in other countries. The FDA-approved products now in use combine all three vaccines in one shot. The CDC’s existing guidance also states that there is no published scientific evidence demonstrating a health benefit from separating the three components. Development, approval, manufacturing and distribution of individual vaccines would therefore have to occur before parents could choose that option.

The recommendation to spread vaccines across additional appointments also raises a practical—and potentially significant—question for families: Who will pay for the additional visits? And will parents be able to keep track of the multiple shots and keep appointments for them. That will require a follow-up reminder from pediatricians, albeit a layer of “work” for busy practices.

Recommended childhood vaccines and their administration are generally covered without cost-sharing when provided by an in-network provider. However, that does not necessarily guarantee that every separately scheduled office visit will also be free. Under existing federal insurance rules, an insurer may in some circumstances charge a copayment or other cost-sharing for an office visit when the preventive service is billed separately. The executive order and accompanying White House fact sheet do not clearly explain whether parents choosing to separate vaccines would be protected from multiple office-visit charges.

That issue will require clarification from the Department of Health and Human Services, insurance carriers and medical providers. Without such protection, an option intended to expand parental choice could prove more accessible to families able to afford several appointments than to those who cannot.

Up to states for school requirements – Up to parents and their pediatricians working together

The order also advises states with school vaccination requirements to review the new federal recommendations and consider changing their laws. It does not, by itself, eliminate or rewrite existing state requirements. Any resulting change in Rhode Island would have to occur through the appropriate state legislative or regulatory process.

Federal agencies are being directed to advance the new framework within their respective authority, while the HHS Task Force on Safer Childhood Vaccines must present the president with additional plans for vaccine research, safety monitoring and expanded options for parents.

The White House says the recommendations are based on a January 2026 HHS assessment comparing the United States with other developed countries. According to the administration, that review found that the United States recommends more childhood vaccines and doses than its peer nations. The assessment identified 11 vaccines that it says are consistently recommended across the countries studied, while concluding that other vaccines could be addressed through individualized decisions between families and medical professionals.

The initiative builds upon the administration’s broader Make America Healthy Again agenda, including the February 2025 creation of the MAHA Commission, changes to the universal childhood COVID-19 vaccine recommendation, a December 2025 presidential memorandum directing a comparison with other developed countries and a May 2026 executive order beginning the realignment of the federal childhood vaccine schedule.

There are questions about added costs involving more office visits and vaccination giving.  Federal guidance says the vaccine and its administration generally must be covered without cost-sharing, but a separately billed office visit can sometimes carry a charge. CMS explains the existing distinction here. The CDC also presently says single-antigen measles vaccine is unavailable, making that another major unanswered implementation question.

The complete Executive Order as published:

Section 1.  Purpose and Policy.  Pursuant to the Presidential Memorandum of December 5, 2025 (Aligning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries), the Department of Health and Human Services (HHS) completed a scientific assessment, which identified a set of consensus vaccines that are consistently recommended in all peer countries and found that the United States currently recommends more childhood vaccines than any peer nation, including more than twice as many vaccine doses as some European nations (scientific assessment).  The scientific assessment also found that, instead of implementing vaccination mandates, most peer nations maintain high childhood vaccination rates through public trust and education.  In the United States, by contrast, individual States set mandatory vaccination requirements that children must meet to attend school.

Executive Order 14407 of May 29, 2026 (Realigning United States Core Childhood Vaccine Recommendations With Best Practices From Peer, Developed Countries), committed the Federal Government to ensuring that Americans are receiving the best scientifically supported medical advice in the world, as well as to protecting religious liberty and parental authority.  However, implementation of my Administration’s prior directives regarding childhood vaccines has been delayed due to litigation over the composition of the Advisory Committee on Immunization Practices and separate updates to the Federal vaccine schedule.  Therefore, I am taking further action to reaffirm that it is the policy of the United States that the core childhood vaccine recommendations should be aligned with scientific evidence and best practices from peer, developed countries while preserving access to vaccines currently available to Americans.  Further, it is the policy of my Administration that Federal programs and funding should support maximal parental choice over childhood vaccines, consistent with the Federal Government’s constitutional and statutory obligations and the fundamental principles of personal autonomy and informed consent.

Sec. 2.  Recommendations for Childhood and Adolescent Vaccines.  (a)  Based on consultation with my advisors and review of available scientific evidence, it is hereby declared that the United States recognizes Gold Standard Childhood Vaccine Recommendations informed by the three distinct categories of childhood immunization recommendations identified in the scientific assessment, as specified below:

(i)    immunizations recommended for all children:  measles, mumps, rubella, diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type B, pneumococcal disease, human papillomavirus, and varicella;

(ii)   immunizations recommended for certain high-risk groups or populations:  respiratory syncytial virus monoclonal antibodies, hepatitis A, hepatitis B, meningococcal B, meningococcal ACWY, and dengue; and

(iii)  immunizations based on shared clinical decision-making:  hepatitis A, hepatitis B, rotavirus, meningococcal disease, influenza, and COVID-19.

(b)  The Gold Standard Childhood Vaccine Recommendations also recognize that the combined measles, mumps, rubella (MMR) vaccine should be administered in three separate single-disease shots once such products are domestically available and that, to the maximum extent feasible, all childhood immunizations should be administered at separate medical visits.

(c)  Each executive department and agency shall review the Gold Standard Childhood Vaccine Recommendations and take any appropriate steps to advance them, to the fullest extent allowable by law.

(d)  States and territories are advised to review the Gold Standard Childhood Vaccine Recommendations and consider updating relevant laws and regulations that define the scope of immunization requirements for contexts such as school enrollment and attendance based on the scientific assessment and best practices from peer, developed countries.

(e)  The United States will routinely reassess the Gold Standard Childhood Vaccine Recommendations according to the findings of the HHS Task Force on Safer Childhood Vaccines as specified in section 3 of this order.

Sec. 3.  Improving Vaccine Research and Options for American Parents.  The Secretary of HHS, through the HHS Task Force on Safer Childhood Vaccines, shall, within 90 days of the date of this order, present plans to the President through the Assistant to the President for Domestic Policy to, to the extent appropriate and consistent with applicable law:

(a)  offer options to administer core childhood vaccines, starting with MMR, as single vaccines rather than combination products/doses, including by working with the private sector and other countries as appropriate, while guaranteeing continued availability of combination vaccines and those vaccines recommended for shared clinical decision-making;

(b)  assess the ideal timing and sequencing of all core childhood vaccines and adjust the Federal childhood and adolescent vaccine schedule as appropriate based on gold‑standard science;

(c)  develop additional alternative adjuvants to aluminum and conduct comparative safety and efficacy studies;

(d)  ensure continuous evaluation of the risk/benefit profiles of all childhood vaccines based on United States and international data; and

(e)  improve vaccine safety monitoring, transparency, and research.

Sec. 4.  Maximizing Parental Choice over Childhood Vaccines.  (a)  The Attorney General shall take appropriate measures to further meritorious legal actions challenging State laws that conflict with States’ constitutional and Federal statutory obligations related to parental authority, religious freedom, disability accommodations, and equal protection under the law, including, to the extent applicable under Federal law, States’ obligations to provide religious and medical exemptions from childhood and adolescent immunization requirements.

(b)  The Departments of Justice, Education, and HHS shall take appropriate action to ensure that their contractors and grantees, including States and localities, are compliant with their constitutional and Federal statutory obligations related to parental authority, religious freedom, disability accommodations, and equal protection under the law, including, to the extent applicable under Federal law, their obligations to provide religious and medical exemptions from childhood and adolescent immunization requirements.

Sec. 5.  General Provisions.  (a)  Nothing in this order shall be construed to impair or otherwise affect:

(i)   the authority granted by law to an executive department or agency, or the head thereof; or

(ii)  the functions of the Director of the Office of Management and Budget relating to budgetary, administrative, or legislative proposals.

(b)  This order shall be implemented consistent with applicable law and subject to the availability of appropriations.

(c)  This order is not intended to, and does not, create any right or benefit, substantive or procedural, enforceable at law or in equity by any party against the United States, its departments, agencies, or entities, its officers, employees, or agents, or any other person.

(d)  The costs for publication of this order shall be borne by the Department of Health and Human Services.

___

Some immediate responses:

American Academy of Pediatrics President Dr. Andrew Racine said the announcement creates unnecessary uncertainty, fear and confusion. His central response: “Science about vaccines and their efficacy has not changed.” The AAP says its existing schedule should remain in place.

The American Medical Association released a formal statement saying that changing a proven schedule without credible evidence could weaken confidence and endanger children.

The Independent Medical Alliance, a coalition of doctors, health providers and researchers, formally “applauded” the order. Dr. Kat Lindley called it “a big step toward restoring sanity” by strengthening parental authority and spacing vaccines.

The Children’s Health Defense offered qualified support. Chief science officer Brian Hooker called it “a step in the right direction,” although he said it did not go far enough in reducing the number of shots given during individual appointments.